BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33058141)

  • 21. Regulatory T Cell-Dependent and -Independent Mechanisms of Immune Suppression by CD28/B7 and CD40/CD40L Costimulation Blockade.
    Vogel I; Verbinnen B; Van Gool S; Ceuppens JL
    J Immunol; 2016 Jul; 197(2):533-40. PubMed ID: 27288533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human regulatory T cells suppress proliferation of B lymphoma cells.
    Grygorowicz MA; Biernacka M; Bujko M; Nowak E; Rymkiewicz G; Paszkiewicz-Kozik E; Borycka IS; Bystydzienski Z; Walewski J; Markowicz S
    Leuk Lymphoma; 2016 Aug; 57(8):1903-20. PubMed ID: 26758248
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulatory T cells engineered with a novel insulin-specific chimeric antigen receptor as a candidate immunotherapy for type 1 diabetes.
    Tenspolde M; Zimmermann K; Weber LC; Hapke M; Lieber M; Dywicki J; Frenzel A; Hust M; Galla M; Buitrago-Molina LE; Manns MP; Jaeckel E; Hardtke-Wolenski M
    J Autoimmun; 2019 Sep; 103():102289. PubMed ID: 31176558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Consequences of double negative regulatory T cell and antigen presenting cell interaction on immune response suppression.
    Ford McIntyre MS; Gao JF; Li X; Naeini BM; Zhang L
    Int Immunopharmacol; 2011 May; 11(5):597-603. PubMed ID: 21109036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absence of Stat1 in donor CD4⁺ T cells promotes the expansion of Tregs and reduces graft-versus-host disease in mice.
    Ma H; Lu C; Ziegler J; Liu A; Sepulveda A; Okada H; Lentzsch S; Mapara MY
    J Clin Invest; 2011 Jul; 121(7):2554-69. PubMed ID: 21670504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amelioration of acute graft-versus-host disease by adoptive transfer of ex vivo expanded human cord blood CD4+CD25+ forkhead box protein 3+ regulatory T cells is associated with the polarization of Treg/Th17 balance in a mouse model.
    Yang J; Fan H; Hao J; Ren Y; Chen L; Li G; Xie R; Yang Y; Qian K; Liu M
    Transfusion; 2012 Jun; 52(6):1333-47. PubMed ID: 22098312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ex-vivo expanded baboon CD4+ CD25 Hi Treg cells suppress baboon anti-pig T and B cell immune response.
    Singh AK; Seavey CN; Horvath KA; Mohiuddin MM
    Xenotransplantation; 2012; 19(2):102-11. PubMed ID: 22497512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD40-activated B cells are more potent than immature dendritic cells to induce and expand CD4(+) regulatory T cells.
    Zheng J; Liu Y; Lau YL; Tu W
    Cell Mol Immunol; 2010 Jan; 7(1):44-50. PubMed ID: 20081875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human HLA-DR+CD27+ regulatory T cells show enhanced antigen-specific suppressive function.
    Ma X; Cao L; Raneri M; Wang H; Cao Q; Zhao Y; Bediaga NG; Naselli G; Harrison LC; Hawthorne WJ; Hu M; Yi S; O'Connell PJ
    JCI Insight; 2023 Dec; 8(23):. PubMed ID: 37874660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Augmented Expansion of Treg Cells From Healthy and Autoimmune Subjects
    Reading JL; Roobrouck VD; Hull CM; Becker PD; Beyens J; Valentin-Torres A; Boardman D; Lamperti EN; Stubblefield S; Lombardi G; Deans R; Ting AE; Tree T
    Front Immunol; 2021; 12():716606. PubMed ID: 34539651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Developing in vitro expanded CD45RA+ regulatory T cells as an adoptive cell therapy for Crohn's disease.
    Canavan JB; Scottà C; Vossenkämper A; Goldberg R; Elder MJ; Shoval I; Marks E; Stolarczyk E; Lo JW; Powell N; Fazekasova H; Irving PM; Sanderson JD; Howard JK; Yagel S; Afzali B; MacDonald TT; Hernandez-Fuentes MP; Shpigel NY; Lombardi G; Lord GM
    Gut; 2016 Apr; 65(4):584-94. PubMed ID: 25715355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unique properties of thymic antigen-presenting cells promote epigenetic imprinting of alloantigen-specific regulatory T cells.
    Garg G; Nikolouli E; Hardtke-Wolenski M; Toker A; Ohkura N; Beckstette M; Miyao T; Geffers R; Floess S; Gerdes N; Lutgens E; Osterloh A; Hori S; Sakaguchi S; Jaeckel E; Huehn J
    Oncotarget; 2017 May; 8(22):35542-35557. PubMed ID: 28415767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Engineering of regulatory T cells by means of mRNA electroporation in a GMP-compliant manner.
    Janssens I; Campillo Davó D; Van den Bos J; De Reu H; Berneman ZN; Wens I; Cools N
    Cytotherapy; 2022 Jun; 24(6):659-672. PubMed ID: 35193826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative study of regulatory T cells expanded ex vivo from cord blood and adult peripheral blood.
    Fan H; Yang J; Hao J; Ren Y; Chen L; Li G; Xie R; Yang Y; Gao F; Liu M
    Immunology; 2012 Jun; 136(2):218-30. PubMed ID: 22348606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Highly Purified Alloantigen-Specific Tregs From Healthy and Chronic Kidney Disease Patients Can Be Long-Term Expanded, Maintaining a Suppressive Phenotype and Function in the Presence of Inflammatory Cytokines.
    Cortés-Hernández A; Alvarez-Salazar EK; Arteaga-Cruz S; Rosas-Cortina K; Linares N; Alberú Gómez JM; Soldevila G
    Front Immunol; 2021; 12():686530. PubMed ID: 34777330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Infusion of ex vivo expanded homologous CD4⁺;CD25⁺; regulatory T cells promotes the susceptibility to tumor in mice].
    Guo T; Luo S; Xu J; Dai J; Liu Z; Gao X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 May; 30(5):466-70. PubMed ID: 24796739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A rapid diagnostic test for human regulatory T-cell function to enable regulatory T-cell therapy.
    Canavan JB; Afzali B; Scottà C; Fazekasova H; Edozie FC; Macdonald TT; Hernandez-Fuentes MP; Lombardi G; Lord GM
    Blood; 2012 Feb; 119(8):e57-66. PubMed ID: 22219224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A converse 4-1BB and CD40 ligand expression pattern delineates activated regulatory T cells (Treg) and conventional T cells enabling direct isolation of alloantigen-reactive natural Foxp3+ Treg.
    Schoenbrunn A; Frentsch M; Kohler S; Keye J; Dooms H; Moewes B; Dong J; Loddenkemper C; Sieper J; Wu P; Romagnani C; Matzmohr N; Thiel A
    J Immunol; 2012 Dec; 189(12):5985-94. PubMed ID: 23162126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical-Grade Expanded Regulatory T Cells Are Enriched with Highly Suppressive Cells Producing IL-10, Granzyme B, and IL-35.
    Ulbar F; Villanova I; Giancola R; Baldoni S; Guardalupi F; Fabi B; Olioso P; Capone A; Sola R; Ciardelli S; Del Papa B; Brattelli A; Ricciardi I; Taricani S; Sabbatinelli G; Iuliani O; Passeri C; Sportoletti P; Santarone S; Pierini A; Calabrese G; Falzetti F; Bonfini T; Accorsi P; Ruggeri L; Martelli MF; Velardi A; Di Ianni M
    Biol Blood Marrow Transplant; 2020 Dec; 26(12):2204-2210. PubMed ID: 32961369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL-6 and TNFα Drive Extensive Proliferation of Human Tregs Without Compromising Their Lineage Stability or Function.
    Skartsis N; Peng Y; Ferreira LMR; Nguyen V; Ronin E; Muller YD; Vincenti F; Tang Q
    Front Immunol; 2021; 12():783282. PubMed ID: 35003100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.